<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00633711</url>
  </required_header>
  <id_info>
    <org_study_id>CNR-IBIM-001</org_study_id>
    <nct_id>NCT00633711</nct_id>
  </id_info>
  <brief_title>Effects of Obstructive Sleep Apnea Treatment by Fixed CPAP and by Auto-CPAP (Somnosmart2)</brief_title>
  <official_title>Differential Effects of Chronic Treatment of OSAS by CPAP and SOMNOsmart2 on Norepinephrine and Blood Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione C.N.R./Regione Toscana &quot;G. Monasterio&quot;, Pisa, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Weinmann Geräte für Medizin GmbH + Co. KG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondazione C.N.R./Regione Toscana &quot;G. Monasterio&quot;, Pisa, Italy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to investigate if treatment of obstructive sleep apnea
      syndrome (OSAS) by continuous positive airway pressure (CPAP) given by a traditional CPAP
      device administering a fixed air pressure, or by one automatic CPAP device (&quot;Somnosmart2&quot;,
      Weinmann, Hamburg) administering variable pressures, have different effects on sympathetic
      nervous system tone (as reflected by urinary excretion of norepinephrine and its catabolite
      normetanephrine) and on blood pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A nocturnal home cardiorespiratory recording will performed for diagnosis of OSA. During the
      same night, patients will be asked to collect their urines. Twentyfour-hour ambulatory BP
      monitoring (ABPM) will be performed starting from the next morning. After analysis of the
      polygraphic recording, subjects with AHI &lt;15 will be excluded from the study, while CPAP will
      be proposed as a treatment to the other patients.

      Before starting treatment, a full night standard polysomnography will be performed: in
      subjects assigned to fixed CPAP for attended CPAP titration; in the other subjects during
      application of the Somnosmart2 device, to verify if obstructive events are adequately
      eliminated by it.

      After analysis of polysomnography, patients will be given a fixed CPAP or the auto-CPAP
      device for nocturnal home use. Two months later, compliance to treatment will be verified
      measured by the in-built time counter of the devices. Then, cardiorespiratory monitoring
      during application of the device used for treatment, nocturnal urine collection and 24-hour
      ABPM will be repeated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure and urinary catecholamines after conventional or auto-CPAP</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relationship between catecholamines / blood pressure changes and compliance to treatment</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <arm_group>
    <arm_group_label>fixed CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Auto-CPAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Auto-CPAP Weinmann &quot;Somnosmart2&quot;</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Automatic (variable, automatically controlled) pressure CPAP</intervention_name>
    <description>CPAP at a variable level according to instantaneous patients' needs for treatment of sleep respiratory disorders, as evaluated by machine's software.
Home nocturnal usage. Two-month treatment.</description>
    <arm_group_label>Auto-CPAP</arm_group_label>
    <other_name>Automatic CPAP &quot;SOMNOsmart2&quot;, Weinmann, Hamburg Germany</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fixed continuous positive airway pressure (CPAP)</intervention_name>
    <description>CPAP at a constant level, whose efficacy on respiratory disorders has been determined by nocturnal titration.
Home nocturnal usage. Two-month treatment.</description>
    <arm_group_label>fixed CPAP</arm_group_label>
    <other_name>fixed CPAP, constant level CPAP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obstructive sleep apnea syndrome deserving CPAP treatment

        Exclusion Criteria:

          -  current pharmacological treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oreste Marrone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione C.N.R./Regione Toscana &quot;G. Monasterio&quot;, Pisa, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Research Council - Institute of Biomedicine and Molecular Immunology (CNR - IBIM)</name>
      <address>
        <city>Palermo</city>
        <zip>90146</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Patruno V, Aiolfi S, Costantino G, Murgia R, Selmi C, Malliani A, Montano N. Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea. Chest. 2007 May;131(5):1393-9.</citation>
    <PMID>17494789</PMID>
  </reference>
  <reference>
    <citation>Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007 Aug;50(2):417-23. Epub 2007 Jun 4. Review.</citation>
    <PMID>17548722</PMID>
  </reference>
  <reference>
    <citation>Alajmi M, Mulgrew AT, Fox J, Davidson W, Schulzer M, Mak E, Ryan CF, Fleetham J, Choi P, Ayas NT. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung. 2007 Mar-Apr;185(2):67-72. Epub 2007 Mar 28.</citation>
    <PMID>17393240</PMID>
  </reference>
  <reference>
    <citation>Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A, Velkeniers B. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007 Apr 23;167(8):757-64.</citation>
    <PMID>17452537</PMID>
  </reference>
  <reference>
    <citation>Parati G, Lombardi C, Narkiewicz K. Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am J Physiol Regul Integr Comp Physiol. 2007 Oct;293(4):R1671-83. Epub 2007 Jul 25. Review.</citation>
    <PMID>17652356</PMID>
  </reference>
  <reference>
    <citation>Narkiewicz K, Somers VK. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand. 2003 Mar;177(3):385-90. Review.</citation>
    <PMID>12609010</PMID>
  </reference>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2008</study_first_submitted>
  <study_first_submitted_qc>March 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2008</study_first_posted>
  <last_update_submitted>June 15, 2011</last_update_submitted>
  <last_update_submitted_qc>June 15, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 16, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr Oreste Marrone</name_title>
    <organization>National Research Council, Inst. of Biomedicine and Molecular Immunology, Italy</organization>
  </responsible_party>
  <keyword>OSAS</keyword>
  <keyword>blood pressure</keyword>
  <keyword>sympathetic nervous system</keyword>
  <keyword>treatment</keyword>
  <keyword>CPAP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

